What is the likely cause and recommended work‑up for a patient with increased mean corpuscular volume (MCV) and mean corpuscular hemoglobin (MCH), low red‑cell distribution width (RDW), and normal hemoglobin (Hgb) and hematocrit (Hct)?

Macrocytosis with Low RDW: Likely Causes and Diagnostic Approach

This laboratory pattern—elevated MCV and MCH with low RDW and normal hemoglobin/hematocrit—indicates a uniform population of enlarged red cells without anemia, most commonly caused by medication effects (especially thiopurines), alcohol use, hypothyroidism, or early vitamin B12/folate deficiency that has not yet produced anemia. 1

Understanding the Laboratory Pattern

A low RDW (< 14%) combined with macrocytosis indicates homogeneous enlargement of red blood cells, which helps distinguish this from iron-deficiency anemia (which typically shows high RDW) and suggests a single underlying process rather than mixed deficiencies. 1

The absence of anemia (normal Hgb and Hct) indicates that erythropoiesis remains adequate despite the morphologic abnormality, pointing away from advanced nutritional deficiencies or bone marrow failure. 1

Primary Differential Diagnosis

Medication-Induced Macrocytosis

• Thiopurine therapy (azathioprine, 6-mercaptopurine) frequently produces homogeneous macrocytosis through myelosuppressive activity rather than vitamin deficiency, particularly in patients with inflammatory bowel disease. 1, 2
• Other common culprits include anticonvulsants, methotrexate, and chemotherapy agents. 1

Alcohol Use

• Chronic alcohol consumption causes macrocytosis through direct toxic effects on erythropoiesis, typically producing a uniform population of enlarged cells. 1

Hypothyroidism

• Thyroid hormone deficiency slows red cell maturation, resulting in macrocytosis with low RDW. 1

Early Vitamin B12 or Folate Deficiency

• Megaloblastic anemia (vitamin B12 or folate deficiency) characteristically presents with macrocytosis and a low/normal reticulocyte count, though in early stages hemoglobin may remain normal. 1

Recommended Diagnostic Work-Up

First-Line Laboratory Tests

1. Obtain a reticulocyte count immediately to differentiate impaired erythropoiesis (low/normal count) from hemolysis or marrow regeneration (elevated count). 1, 2

   • A low or normal reticulocyte count points to impaired erythropoiesis from vitamin deficiency, medication effects, or bone marrow disorders. 1
   • An elevated reticulocyte count suggests hemolysis or recent hemorrhage and requires hemolysis evaluation with haptoglobin, LDH, and indirect bilirubin. 1, 2

2. Measure serum vitamin B12 and folate levels to confirm or exclude megaloblastic anemia, even when hemoglobin is normal. 1, 2

   • If serum B12 is borderline (200-400 pg/mL), order methylmalonic acid (specific for B12 deficiency with better sensitivity than serum B12) and homocysteine (elevated in both B12 and folate deficiency). 2

3. Obtain thyroid-stimulating hormone (TSH) to rule out hypothyroidism, a common reversible cause of macrocytosis. 1

4. Check serum ferritin and transferrin saturation to exclude concurrent iron deficiency, which can mask macrocytosis and normalize the MCV. 1, 2

   • In inflammatory conditions, ferritin up to 100 µg/L may still indicate iron deficiency. 1, 2
   • MCH is more reliable than MCHC for detecting iron deficiency because it is less dependent on storage conditions; a reduced MCH despite macrocytosis suggests mixed micro- and macrocytosis requiring iron studies. 2

5. Perform a peripheral blood smear to look for hypersegmented neutrophils (megaloblastic), oval macrocytes, or other morphologic abnormalities. 1

Targeted Clinical History

• Review all medications, focusing on thiopurines, chemotherapy agents, anticonvulsants, and methotrexate, as these commonly induce macrocytosis. 1, 2
• Quantify alcohol consumption over the past several months. 1
• Assess gastrointestinal history (chronic diarrhea, malabsorption, prior gastric surgery, inflammatory bowel disease) that raises the risk of vitamin B12 deficiency. 1

Common Diagnostic Pitfalls

• Mixed nutrient deficiencies (iron + vitamin B12 or folate) can neutralize the MCV, yielding a normal MCV but an elevated RDW; therefore, iron studies remain essential even when RDW is low. 1, 2
• Approximately 10% of patients with iron deficiency have a normal RDW, so a low RDW does not exclude iron deficiency—always check ferritin and transferrin saturation. 3
• In patients with inflammatory bowel disease and other chronic inflammatory conditions, MCH evaluation is particularly important because these patients often have mixed nutrient deficiencies that can be masked by macrocytosis. 2
• Ferritin interpretation requires clinical context because it can be falsely elevated in inflammation, chronic disease, malignancy, or liver disease. 1

Management Based on Etiology

If Vitamin B12 Deficiency is Confirmed

• Patients with pernicious anemia require monthly intramuscular injections of vitamin B12 for life; failure to do so will result in return of anemia and irreversible spinal cord damage. 4
• Vitamin B12 deficiency that progresses for longer than 3 months may produce permanent degenerative lesions of the spinal cord. 4
• Patients should be warned about the danger of taking folic acid in place of vitamin B12, because folic acid may prevent anemia but allow progression of subacute combined degeneration. 4

If Medication-Induced

• Identify and address the underlying cause by reviewing medications with the prescribing physician to discuss risk/benefit, particularly for thiopurines in inflammatory bowel disease patients. 2

If Etiology Remains Unclear

• Regular CBC monitoring is necessary to track MCV and ensure stability; reassess B12 and folate levels periodically, even with initially normal levels, as deficiencies may develop over time. 2
• Consider hematology consultation if the cause remains unclear after initial workup, if there are other concerning hematologic abnormalities, or if severe or progressively worsening macrocytosis develops. 2
• When pancytopenia is identified, bone marrow examination is warranted to evaluate for aplastic anemia or myelodysplastic syndrome. 1

Practical Diagnostic Algorithm

1. Order reticulocyte count, vitamin B12, folate, TSH, ferritin, transferrin saturation, and peripheral blood smear. 1, 2

2. If reticulocyte count is low/normal:

   • Proceed with vitamin supplementation if B12 or folate is deficient. 1
   • Treat hypothyroidism if TSH is elevated. 1
   • Review and potentially discontinue causative medications. 2
   • If all initial tests are normal, monitor CBC every 3-6 months. 2

3. If reticulocyte count is elevated:

   • Evaluate for hemolysis with haptoglobin, LDH, indirect bilirubin, and direct antiglobulin test. 1, 2

4. If iron studies reveal deficiency (ferritin < 30 µg/L or < 100 µg/L with inflammation):

   • Initiate iron supplementation and investigate for gastrointestinal blood loss. 1, 2

5. If initial investigations are nondiagnostic and macrocytosis persists or worsens:

   • Refer to hematology for possible bone marrow examination or hemoglobin electrophoresis. 1, 2